These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 3509404

  • 1. Penetration of imipenem-cilastatin into the lung tissue and pericardial fluid of thoracotomized patients.
    Benoni G, Cuzzolin L, Bertrand C, Pucchetti V, Velo G.
    Chemioterapia; 1987 Jun; 6(2 Suppl):259-60. PubMed ID: 3509404
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of imipenem-cilastatin following intravenous administration in healthy adult horses.
    Orsini JA, Moate PJ, Boston RC, Norman T, Engiles J, Benson CE, Poppenga R.
    J Vet Pharmacol Ther; 2005 Aug; 28(4):355-61. PubMed ID: 16050815
    [Abstract] [Full Text] [Related]

  • 4. [Study of the intraperitoneal penetration of imipenem/cilastatin in acute peritonitis with perforation].
    Pezé P, Mounier M, Cevallos R, Denis F.
    Pathol Biol (Paris); 1990 Jun; 38(5 ( Pt 2)):504-7. PubMed ID: 2385446
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Imipenem-cilastatin sodium.
    Roach AC.
    Crit Care Nurse; 1989 Mar; 9(3):14-8. PubMed ID: 2582800
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. New antibiotics: carbapenems, monobactams and quinolones.
    Amin NM.
    Am Fam Physician; 1988 Oct; 38(4):125-34. PubMed ID: 3051970
    [Abstract] [Full Text] [Related]

  • 9. A randomized prospective study of cefepime plus metronidazole with imipenem-cilastatin in the treatment of intra-abdominal infections.
    Garbino J, Villiger P, Caviezel A, Matulionyte R, Uckay I, Morel P, Lew D.
    Infection; 2007 Jun; 35(3):161-6. PubMed ID: 17565457
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics of imipenem-cilastatin in critically ill patients undergoing continuous venovenous hemofiltration.
    Tegeder I, Bremer F, Oelkers R, Schobel H, Schüttler J, Brune K, Geisslinger G.
    Antimicrob Agents Chemother; 1997 Dec; 41(12):2640-5. PubMed ID: 9420033
    [Abstract] [Full Text] [Related]

  • 11. [Clinical pharmacokinetics of an imipenem-cilastatin combination].
    Singlas E.
    Presse Med; 1990 Apr 04; 19(13):598-605. PubMed ID: 2139939
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics of parenteral imipenem/cilastatin in patients on continuous ambulatory peritoneal dialysis.
    Chan CY, Lai KN, Lam AW, Li PK, Chung WW, French GL.
    J Antimicrob Chemother; 1991 Feb 04; 27(2):225-32. PubMed ID: 2055813
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of the efficacy and safety of imipenem/cilastatin in the treatment of complicated urinary tract infections.
    Goldoni S, Gandolfi P, Tubaro A, Vicentini C, Lancione P, Miano L.
    J Chemother; 1989 Jul 04; 1(4 Suppl):845-7. PubMed ID: 16312665
    [No Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of intravenous imipenem/cilastatin during intermittent haemofiltration.
    Alarabi AA, Cars O, Danielson BG, Salmonson T, Wikström B.
    J Antimicrob Chemother; 1990 Jul 04; 26(1):91-8. PubMed ID: 2211452
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data.
    Babinchak T, Ellis-Grosse E, Dartois N, Rose GM, Loh E, Tigecycline 301 Study Group, Tigecycline 306 Study Group.
    Clin Infect Dis; 2005 Sep 01; 41 Suppl 5():S354-67. PubMed ID: 16080073
    [Abstract] [Full Text] [Related]

  • 20. Imipenem/cilastatin as initial single-agent therapy for infections in cancer patients with neutropenia.
    Fassas A, Papageorgiou T, Kontodimou A, Proya E, Hadjikyrkou M, Anagnostopoulos A.
    J Chemother; 1989 Jul 01; 1(4 Suppl):1295-7. PubMed ID: 16312872
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.